New from the Proscia blog: Digital pathology has evolved far beyond improving quality and efficiency. It’s becoming a strategic gateway to business growth. This was the central message our CEO David West delivered during his breakout...

As life sciences R&D teams increasingly leverage digital pathology and AI to accelerate their precision medicine programs, Proscia’s Concentriq LS platform is handling unprecedented volumes of high-resolution images, complex annotations,...

Proscia: Honored alongside Abbott, Johnson & Johnson, IQVIA, and ŌURA PHILADELPHIA —May 8, 2025—Proscia®, a software company leading pathology’s transition to digital and AI, has been named a winner in the 2025 MedTech...

New on the Proscia bMaximize your digital investment with pathologist-centered innovation Here at Proscia, we believe the key to achieving productivity and confidence in digital pathology lies in delivering an intelligent and intuitive...

The United States and Canadian Academy of Pathology (USCAP) Annual Meeting is always a standout—a forum for trading the latest insights, engaging with the Concentriq community, and enjoying time with our team. This year’s event was no...

Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best course of treatment Funding led by global software investor Insight Partners comes...